Among these effects, CIN achieves carbohydrate balance by inducing insulin and glucagon-like peptide-1 secretion, the inhibition of intestinal disaccharidases, and, consequently, improves glucose tolerance. This evidence concerns the gene INS and cervical squamous intraepithelial neoplasia.